The Press Room

FOX 2 With the recent announcement of former President Joe Biden’s metastatic prostate cancer diagnosis, Boris Pasche, M.D., Ph.D., FACP, president and CEO of the Barbara Ann Karmanos Cancer Institute, joined FOX 2 to discuss the prognosis of cancer that has spread to the bones, treatment and screening options. Watch the interview here . Learn more about prostate cancer and screening here .

The Barbara Ann Karmanos Cancer Institute ’s Office of Community Outreach and Engagement (COE) is partnering with the Detroit Library to present the 2025 Community Conversations on Cancer series. The community is invited to learn from cancer researchers and physician scientists as they provide the latest updates in cancer care and leading-edge research discoveries at Karmanos. The first session, titled The Next Breakthrough in Cancer: Treatment with Radiofrequencies , will be presented by Boris Pasche, ...

TheSkimm It’s not unusual to ask for a second opinion for a health diagnosis. Eliza Wright Beal, M.D., MS , surgical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  at Karmanos, contributed to a script patients can use when they go for a second opinion. This script includes questions to ask, tips, what patients may need to prepare for the visit, and what they should do after the visit. Read the script here . (This article may require a subscri...

9&10 News The 2025 CAPABLE session in Petoskey is free for cancer survivors. Jennifer Beebe-Dimmer, Ph.D., MPH, leader of the  Population Studies and Disparities Research (PSDR) Program , scientific director of the  Epidemiology Research Core  at Karmanos and professor of Oncology at Wayne State University, shared with Good Day Northern Michigan what CAPABLE is and how it helps cancer survivors gain the benefits of staying active after a diagnosis. She also explained how CAPABLE coach...

Patient Power Why might a prostate cancer patient feel tired? Frank Cackowski, M.D., Ph.D. , medical oncologist and member of the Genitourinary Oncology Multidisciplinary Team at Karmanos, explained some of the causes of fatigue and how prostate cancer patients can manage the tiredness they may feel while undergoing treatment. Read the article here .

Patient Power Steven Lucas, M.D. , urologic oncologist and member of the Genitourinary Oncology Multidisciplinary Team at Karmanos, discussed some differences between prostatitis and prostate cancer. He said the only known risk factor for both is age – one occurs more in younger men, while the other is more common in slightly older men. Read the article here .

Everyday Health Graft-versus-host disease, when a donor’s immune cells start attacking the recipient’s tissue, can occur after a bone marrow or stem cell transplant. Joseph Uberti, M.D., Ph.D. , hematologist and medical oncologist, and leader of the  Bone Marrow & Stem Cell Transplant Multidisciplinary Team , outlined lifestyle changes patients may have to adopt, rehabilitation and pain management for patients with GVHD. Read the article here .

Newsweek In the May 1 edition of Newsweek’s Access Health, Boris Pasche, M.D., Ph.D., FACP, president and CEO of Karmanos, answers two questions: Is there a breakthrough innovation in oncology research that you wish was getting more attention? Which industry trends are you keeping an eye on, and how might they alter cancer researchers’ strategies in the future? Read his answers here .

Hour Detroit In the 2025 Health Guide, Hadeel Assad, M.D. , medical oncologist, co-leader of the Breast Cancer Multidisciplinary Team , member of the  Phase I Clinical Trials MDT , and associate professor in the Department of Oncology at Wayne State University, explained a 2014 study she led with colleagues that examined breast cancer patients and their sexual well-being. Results from the study showed that sexual dysfunction is prevalent among these patients. Dr. Assad shared some recommendations f...

Prevention According to the 2025 Annual Report to the Nation on the Status of Cancer, cancer cases are increasing in women and young adults, but at the same time, the number of cancer deaths in general is going down. Wasif Saif, M.D., MBBS , medical oncologist, co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  (MDT), and leader of the  Phase I Clinical Trials MDT  at Karmanos, explained there is a decrease in cancer deaths due to less people smoki...